Indigocarmin Provingo (Indigo Carmine)

Indigo Carmine is a water‑soluble azo dye that, after intravenous injection, circulates in the bloodstream and binds loosely to plasma proteins. It is filtered unchanged by the kidneys, staining tissues and bodily fluids blue, which creates a visual contrast that enhances the detection of anatomical structures during diagnostic and surgical procedures.

The dose of Indigocarmin Provingo is determined by the prescribing clinician based on the specific diagnostic or surgical requirement, patient weight, and renal function. Healthcare professionals calculate the appropriate volume and concentration at the point of care; no fixed public dosing regimen is provided.

Safety data for Indigo Carmine in pregnancy and lactation are limited. The product should only be used when the potential diagnostic benefit outweighs any possible risk to the fetus or infant. Clinicians should discuss uncertainties with the patient and consider alternative imaging methods when feasible.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Indigocarmin Provingo. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indigo Carmine offers a distinct blue coloration, making it useful for urinary tract visualization and renal function tests, whereas agents like methylene blue provide a different hue and are often used for sentinel lymph node mapping. Compared with iodinated contrast media, Indigo Carmine has a lower risk of nephrotoxicity but does not provide radiopaque imaging capabilities.

Indigocarmin Provingo should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the solution from direct light, moisture, and extreme temperature fluctuations. Do not freeze the product, and inspect the vial for particulate matter before use.

The product is administered intravenously by a qualified healthcare professional. It is supplied as a sterile solution that is injected directly into a peripheral or central vein, typically as a single bolus or slow infusion, depending on the clinical protocol and the diagnostic objective.

Serious adverse events include anaphylactic reactions, severe hypotension or hypertension, methemoglobinemia, acute renal impairment, and cardiac arrhythmias. Immediate medical attention is required if any of these symptoms develop during or after administration.

Patients with a known hypersensitivity to Indigo Carmine or any component of the formulation should avoid the product. It is also contraindicated in individuals with severe renal impairment, uncontrolled hypertension, or a history of methemoglobinemia, unless the clinical benefit justifies the risk.